Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $219,467.00 |
|---|---|
| Enterprise Value | $7.34 Million |
| Earnings per Share | $-0.02 |
| Beta | 1.08 |
| Outstanding Shares | 37,197,757 |
| P/E Ratio | -15.32 |
|---|---|
| PEG | 12.31 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | 1.16 |
| Enterprise Value to EBIT | -1.57 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1 |
| Debt to Equity | -1.22 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Regent Pacific Group Limited is an investment holding company that primarily focuses on the healthcare and life sciences sectors. The company is involved in the research, development, and sale of pharmaceutical products, with a notable f...